Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 69651-69700 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT06010433
CERAMENT G Device Registry
N/A
Recruiting
100 participants
Started: Aug 17, 2023 · Completed: Sep 22, 2028
3 conditions
1 sponsor
3 locations
NCT06400940
Prospective, Post-registration, Interventional, Randomized, in Parallel Groups, Multicenter Eurasian Clinical Study of DERIVO®/DERIVO® Mini Aneurysm Embolization Device, Europe-Asia
PHASE4
Recruiting
640 participants
Started: Aug 17, 2023 · Completed: Aug 31, 2028
1 condition
1 sponsor
1 location
NCT05898022
Pragmatic Research on Diuretic Management in Early BPD Pilot
PHASE4
Active, not recruiting
30 participants
Started: Aug 17, 2023 · Completed: Dec 31, 2025
1 condition
5 sponsors
4 locations
NCT05986890
Roux-en-Y Gastric Bypass Versus Loop Gastrojejunostomy for Malignant Gastric Outlet Obstruction
NA
Recruiting
16 participants
Started: Aug 17, 2023 · Completed: Dec 1, 2026
1 condition
1 sponsor
1 location
NCT05868408
Effect of Partially Hydrolyzed, Whey-based Infant Formulas on Growth and Tolerability in Healthy Term Infants
NA
Recruiting
234 participants
Started: Aug 17, 2023 · Completed: Jun 30, 2028
5 conditions
1 sponsor
3 locations
NCT05978882
Feasibility Study of Sentinel Navigation Surgery in Early Gastric Cancer Using Fluorescence (SENORITA4)
NA
Not yet recruiting
203 participants
Started: Aug 17, 2023 · Completed: Dec 31, 2030
1 condition
9 sponsors
7 locations
NCT05965687
Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke (OPENS-3)
PHASE3
Recruiting
1,230 participants
Started: Aug 17, 2023 · Completed: Oct 30, 2024
1 condition
25 sponsors
1 location
NCT06004752
Efficacy and Safety of CsA+AVA in the Treatment of NSAA in the Elderly
PHASE2
Recruiting
30 participants
Started: Aug 17, 2023 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT05965193
Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke:Longterm Outcome (OPENS-3L)
PHASE3
Recruiting
1,230 participants
Started: Aug 17, 2023 · Completed: Oct 30, 2025
1 condition
20 sponsors
1 location
NCT05907304
A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations
PHASE1
Active, not recruiting
86 participants
Started: Aug 17, 2023 · Completed: Nov 30, 2025
1 condition
1 sponsor
29 locations
NCT04586660
Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone
PHASE4
Active, not recruiting
36 participants
Started: Aug 17, 2023 · Completed: Mar 7, 2028
1 condition
1 sponsor
10 locations
NCT05710406
Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer
PHASE2/PHASE3
Active, not recruiting
1 participants
Started: Aug 16, 2023 · Completed: Jun 1, 2034
5 conditions
2 sponsors
202 locations
NCT05909241
A Study of BA1202 in Patients With Advanced Solid Tumors
PHASE1
Recruiting
78 participants
Started: Aug 16, 2023 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05741502
An Exploratory Analysis of Immune and Inflammatory Response Associated with Clozapine
PHASE4
Recruiting
60 participants
Started: Aug 16, 2023 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05864157
Targeted Motor Learning to Improve Gait for Individuals With Parkinson Disease
NA
Recruiting
45 participants
Started: Aug 16, 2023 · Completed: May 3, 2026
1 condition
2 sponsors
1 location
NCT06149585
Changes in Microbial Status From Dentate, Edentulous and After Dental Implant Placement
N/A
Recruiting
12 participants
Started: Aug 16, 2023 · Completed: May 1, 2027
4 conditions
1 sponsor
1 location
NCT06547762
Hybrid Approach to Pediatric Rehabilitation
NA
Enrolling by invitation
200 participants
Started: Aug 16, 2023 · Completed: Dec 1, 2025
3 conditions
2 sponsors
1 location
NCT06058429
Immunogenicity of After Primary Immunization and Booster Immunization of sIPV
N/A
Active, not recruiting
233 participants
Started: Aug 16, 2023 · Completed: Dec 31, 2023
1 condition
2 sponsors
1 location
NCT06020716
Antibiotics, Microbiology and Immunology in Children With Chronic Wet Cough - the AMIC Study
PHASE4
Recruiting
350 participants
Started: Aug 16, 2023 · Completed: Apr 30, 2028
1 condition
7 sponsors
7 locations
NCT05247450
Conventional-therapy & FES-therapy In-Veritas Effects Study
NA
Recruiting
16 participants
Started: Aug 16, 2023 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT05627375
Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets
PHASE3
Recruiting
1,400 participants
Started: Aug 16, 2023 · Completed: Dec 31, 2028
1 condition
2 sponsors
28 locations
NCT06021483
Observational Study to Evaluate the Safety and Efficacy of Zepzelca™ Injection
N/A
Recruiting
300 participants
Started: Aug 16, 2023 · Completed: Sep 30, 2025
1 condition
1 sponsor
1 location
NCT06892561
Phase-Aligned Atrial Fibrillation Mapping
N/A
Active, not recruiting
320 participants
Started: Aug 16, 2023 · Completed: Aug 16, 2026
1 condition
1 sponsor
1 location
NCT05022459
Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
N/A
Recruiting
120 participants
Started: Aug 16, 2023 · Completed: Mar 31, 2029
1 condition
2 sponsors
7 locations
NCT05908461
The Early Childhood Friendship Project - Phase 3
NA
Recruiting
600 participants
Started: Aug 16, 2023 · Completed: Apr 16, 2027
1 condition
2 sponsors
1 location
NCT06006273
A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid Tumors
PHASE1/PHASE2
Recruiting
48 participants
Started: Aug 16, 2023 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT06858618
FCN-338 in Combination With Azacitidine or Chemotherapy in Myeloid Neoplasms
PHASE2
Active, not recruiting
47 participants
Started: Aug 16, 2023 · Completed: Dec 31, 2026
3 conditions
2 sponsors
1 location
NCT05661266
Investigating Eye-Movement Biomarkers of Disease Severity and Cognition in Multiple Sclerosis
N/A
Recruiting
120 participants
Started: Aug 16, 2023 · Completed: Apr 30, 2025
1 condition
1 sponsor
1 location
NCT06021522
A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder
PHASE3
Active, not recruiting
150 participants
Started: Aug 16, 2023 · Completed: Mar 31, 2027
1 condition
1 sponsor
67 locations
NCT05771480
Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs)
PHASE3
Active, not recruiting
142 participants
Started: Aug 16, 2023 · Completed: Mar 17, 2026
1 condition
1 sponsor
34 locations
NCT05997563
Adjunctive Vaginal Progesterone in Management of Preterm Labor
PHASE4
Recruiting
48 participants
Started: Aug 16, 2023 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT06577792
Lobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY)
NA
Recruiting
620 participants
Started: Aug 16, 2023 · Completed: Dec 31, 2030
1 condition
26 sponsors
26 locations
NCT06084260
Nutritional Counseling Based on Self-compassion Vs. Diet Approach on Body Dissatisfaction and Disordered Eating
NA
Recruiting
76 participants
Started: Aug 16, 2023 · Completed: Dec 19, 2026
2 conditions
1 sponsor
1 location
NCT06991465
Organ Preservation in Rectal AdenoCa Using Hypofractionated Pelvic RT(Hypo-OPRA)
PHASE2
Recruiting
35 participants
Started: Aug 16, 2023 · Completed: Jun 30, 2029
1 condition
2 sponsors
1 location
NCT05490550
Comparing Insomnia Care As Usual to Digital Augmentation (CICADA)
NA
Recruiting
188 participants
Started: Aug 16, 2023 · Completed: Mar 31, 2025
1 condition
1 sponsor
1 location
NCT06251479
Study of the Dynamics of Verbal and Non-verbal Interaction in Healthy Subjects, Through the Recording of Body Movements and Non-invasive Neurophysiological Techniques
NA
Recruiting
200 participants
Started: Aug 16, 2023 · Completed: Aug 16, 2026
2 conditions
1 sponsor
1 location
NCT04092010
Improving Preschool Outcomes by Addressing Maternal Depression in Head Start
NA
Recruiting
388 participants
Started: Aug 16, 2023 · Completed: Apr 30, 2028
1 condition
3 sponsors
1 location
NCT05944978
A Study of GNC-035 in Relapsed or Refractory Chronic Lymphocytic Leukemia and Other Hematological Malignancies
PHASE1/PHASE2
Active, not recruiting
3 participants
Started: Aug 16, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06143540
Clinical Study of 18F-FAPI-RGD in Interstitial Lung Disease Associated With Connective Tissue Disease
N/A
Recruiting
30 participants
Started: Aug 16, 2023 · Completed: Jul 31, 2024
1 condition
1 sponsor
1 location
NCT05936606
Tailored Anti-platelet Therapy After DES Implantation in High-risk Patients
NA
Recruiting
3,434 participants
Started: Aug 16, 2023 · Completed: May 31, 2029
1 condition
1 sponsor
1 location
NCT06063018
RC48 Combined With Tislelizumab for Second-line Treatment of HER2 Expression in Recurrent Cervical Cancer
PHASE2
Recruiting
30 participants
Started: Aug 16, 2023 · Completed: Aug 31, 2026
1 condition
1 sponsor
1 location
NCT06019013
A Study of QLF3108 in Participants With Advanced Solid Tumor
PHASE1
Recruiting
78 participants
Started: Aug 16, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05885555
A Study of Ianalumab (VAY736) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least Two Lines of Therapies
PHASE2
Active, not recruiting
41 participants
Started: Aug 16, 2023 · Completed: Mar 19, 2029
1 condition
1 sponsor
24 locations
NCT05558982
BXCL701 and Pembrolizumab in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
PHASE2
Active, not recruiting
22 participants
Started: Aug 16, 2023 · Completed: Nov 30, 2027
1 condition
3 sponsors
3 locations
NCT05657743
A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer
NA
Recruiting
15 participants
Started: Aug 16, 2023 · Completed: Nov 30, 2025
4 conditions
1 sponsor
2 locations
NCT06007924
A Study of Avutometinib and Defactinib in People With Thyroid Cancer
PHASE2
Recruiting
30 participants
Started: Aug 16, 2023 · Completed: Aug 16, 2027
1 condition
2 sponsors
8 locations
NCT06134895
Tramadol and Tramadol Plus Ketamine for Shivering Prevention After Spinal Anesthesia in Lower Segment Caeserian Section
PHASE4
Recruiting
190 participants
Started: Aug 16, 2023 · Completed: Nov 16, 2023
1 condition
1 sponsor
1 location
NCT06046651
Blood Specimen Collection For Laboratory Assay Research
N/A
Recruiting
10,000 participants
Started: Aug 16, 2023 · Completed: Aug 15, 2033
4 conditions
1 sponsor
1 location
NCT06101615
Effects of IASTM vs. Foam Rolling on Knee and Hip Range of Motion in Soccer Players
NA
Recruiting
10 participants
Started: Aug 15, 2023 · Completed: Jan 31, 2024
1 condition
1 sponsor
1 location
NCT05668650
Double-blind Study to Evaluate the PK, Efficacy, Safety and Immunogenicity of MB12 Versus Keytruda® in Stage IV NSCLC
PHASE3
Recruiting
174 participants
Started: Aug 15, 2023 · Completed: Dec 31, 2024
1 condition
2 sponsors
1 location
Previous
1
More pages
1391
1392
1393
1394
1395
1396
1397
More pages
2369
Next